[Role of midocalm in combined treatment of neuropathic diabetic foot syndrome].
Briskin
B S
BS
Sakunova
T I
TI
Iakobishvili
Ia I
IaI
D000328:Adult; D000368:Aged; D003646:Debridement; D017719:Diabetic Foot / Q000188:drug therapy* / Q000601:surgery; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000601:surgery; D004188:Disarticulation; D004333:Drug Administration Routes; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000627:therapeutic use*; D013577:Syndrome; D014049:Tolperisone / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D009125:Muscle Relaxants, Central; D014665:Vasodilator Agents; D014049:Tolperisone